Form D · Other Health Care
AngioScore Inc.
Fremont, CA · CIK 0001518742
Offering snapshot reported Apr 28, 2011 · SEC filing
- Reported sold
- $12M Offering amount: $12M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 19, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 28, 2011 | Initial | $12,000,002 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-158994
Source: Form D, filed Apr 28, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James B. Andrews | Executive |
| J. Neal Armstrong | Director |
| Robert A. Elliott | Director |
| Scott Halsted | Director |
| Dalia Megiddo | Director |
| Thomas A. Raffin | Director |
| Benjamin S. Schapiro | Director |
| Lisa Suennen | Director |
| Thomas R. Trotter | Director, Executive |
| Jeanette M. Welsh | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
5055 Brandin Court
Fremont, CA, 94538
Fremont, CA, 94538